At the Pharmacity Annual Conference held in Ho Chi Minh City on November 14, 2025, Assoc. Prof. Dr. Nguyen Thi Van Anh – representative of the ANABIO R&D Spobiotic Research Center and scientific advisor to LiveSpo Pharma – delivered a presentation titled “LiveSpo Dia30 and LiveSpo Navax: Multi-strain Bacillus spore formulations supporting the treatment of gastrointestinal and respiratory infections and reducing antibiotic dependence.”
During the presentation, Dr. Van Anh provided an overview of the technology platform and key advantages of the products, as well as clinical evidence from collaborative studies conducted with the Vietnam National Children’s Hospital and Hanoi Medical University. These included clinical trials of LiveSpo Dia30 in children with prolonged diarrhea; LiveSpo Navax in children with RSV–bacterial coinfection pneumonia; and the preventive effects of LiveSpo Navax against respiratory infections in preschool children. The data were shared with more than 500 pharmacists across the Pharmacity system, equipping them with deeper clinical insights into the products.
In addition to demonstrating clear benefits in shortening treatment duration by 1–2 days and reducing antibiotic use by 15–25%, the presentation emphasized the mechanisms of action of these formulations—restoring microbiome balance in both the gut and the nasal cavity, and modulating intestinal and nasal inflammation by reducing excessive pro-inflammatory cytokine secretion while enhancing anti-inflammatory cytokines.
Alongside presentations from major industry partners such as Opella, AstraZeneca, Bayer, GSK, and Meripharmex on topics related to the research, production, and commercialization of gastrointestinal, respiratory, gynecological therapeutics and health supplements, Dr. Van Anh’s report highlighted an innovative approach: the use of LiveSpo Bacillus spore probiotics to rapidly improve symptoms, shorten treatment time, and reduce the need for antibiotics. This contribution underscores an important advancement in supporting digestive and respiratory health, particularly for children.
